Literature DB >> 34787697

Anthracycline Treatment and Left Atrial Function in Children: A Real-Time 3-Dimensional Echocardiographic Study.

Dipika Menon1, Gilda Kadiu2, Yamuna Sanil2, Sanjeev Aggarwal2.   

Abstract

Anthracycline (AC) therapy is associated with left ventricular (LV) dysfunction. Left atrial (LA) size and function are used to assess LV diastolic function in heart failure in adults. Data on LA size and function following AC therapy in children is limited. We hypothesized that LA size and function will be abnormal in children following AC chemotherapy. This retrospective review included patients who received AC for pediatric cancers. Controls had normal echocardiograms performed for evaluation of chest pain, murmur, or syncope. Real-time three-dimensional echocardiography was performed to evaluate LA reservoir, conduit, and booster pump function parameters. In addition to LA volume data, LV shortening fraction, spectral and tissue Doppler variables assessing diastolic function as well as myocardial performance index was obtained. Groups with and without AC therapy were compared by student t-test and chi-square test. We evaluated 136 patients, 55 (40.4%) had received AC. There was no significant difference between the groups in LV shortening fraction, diastolic as well as global function indices. LA reservoir and conduit function parameters were significantly lower in AC group compared to controls. The booster function parameters showed variable results. It is intriguing that AC-treated children have smaller LA reservoir and abnormal booster function. We speculate that these findings may reflect early changes in LA compliance associated with AC exposure. Assessment of LA volumes and function as prognostic markers of AC-induced cardiotoxicity in children is warranted.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  3-dimensional echocardiography; Anthracycline cardiotoxicity; Left atrial function; Left atrial size

Mesh:

Substances:

Year:  2021        PMID: 34787697     DOI: 10.1007/s00246-021-02769-w

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  30 in total

1.  Insights into the evolution of myocardial dysfunction in the functionally single right ventricle between staged palliations using speckle-tracking echocardiography.

Authors:  Edythe B Tham; Jeffery F Smallhorn; Sachie Kaneko; Sabira Valiani; Kimberley A Myers; Timothy M Colen; Shelby Kutty; Nee S Khoo
Journal:  J Am Soc Echocardiogr       Date:  2013-12-25       Impact factor: 5.251

2.  Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines.

Authors:  G Curigliano; D Cardinale; T Suter; G Plataniotis; E de Azambuja; M T Sandri; C Criscitiello; A Goldhirsch; C Cipolla; F Roila
Journal:  Ann Oncol       Date:  2012-10       Impact factor: 32.976

3.  Left ventricular myocardial deformation and mechanical dyssynchrony in children with normal ventricular shortening fraction after anthracycline therapy.

Authors:  Yiu-fai Cheung; Wen-jing Hong; Godfrey C F Chan; Sophia J Wong; Shau-yin Ha
Journal:  Heart       Date:  2010-05-29       Impact factor: 5.994

4.  Predictors of prosthesis survival, growth, and functional status following mechanical mitral valve replacement in children aged <5 years, a multi-institutional study.

Authors:  Geetha Raghuveer; Christopher A Caldarone; Christine B Hills; Dianne L Atkins; John M Belmont; James H Moller
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

5.  Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease.

Authors:  Brandon C Drafts; Katie M Twomley; Ralph D'Agostino; Julia Lawrence; Nancy Avis; Leslie R Ellis; Vinay Thohan; Jennifer Jordan; Susan A Melin; Frank M Torti; William C Little; Craig A Hamilton; W Gregory Hundley
Journal:  JACC Cardiovasc Imaging       Date:  2013-05-01

6.  Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48.

Authors:  Deepak K Gupta; Amil M Shah; Robert P Giugliano; Christian T Ruff; Elliott M Antman; Laura T Grip; Naveen Deenadayalu; Elaine Hoffman; Indravadan Patel; Minggao Shi; Michele Mercuri; Veselin Mitrovic; Eugene Braunwald; Scott D Solomon
Journal:  Eur Heart J       Date:  2013-12-02       Impact factor: 29.983

7.  Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.

Authors:  Javier Ganame; Piet Claus; Anne Uyttebroeck; Marleen Renard; Jan D'hooge; Bart Bijnens; George R Sutherland; Bénédicte Eyskens; Luc Mertens
Journal:  J Am Soc Echocardiogr       Date:  2007-07-02       Impact factor: 5.251

8.  Chronic health conditions in adult survivors of childhood cancer.

Authors:  Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison
Journal:  N Engl J Med       Date:  2006-10-12       Impact factor: 176.079

9.  Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study.

Authors:  A C Mertens; Y Yasui; J P Neglia; J D Potter; M E Nesbit; K Ruccione; W A Smithson; L L Robison
Journal:  J Clin Oncol       Date:  2001-07-01       Impact factor: 50.717

10.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort.

Authors:  Daniel A Mulrooney; Mark W Yeazel; Toana Kawashima; Ann C Mertens; Pauline Mitby; Marilyn Stovall; Sarah S Donaldson; Daniel M Green; Charles A Sklar; Leslie L Robison; Wendy M Leisenring
Journal:  BMJ       Date:  2009-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.